Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Elizabeth R. Bergert"'
Autor:
John C. Morris, Michael K. O'Connor, Roisin M. Dwyer, Elizabeth R. Bergert, Sandra J. Gendler
Publikováno v:
Human Gene Therapy. 17:661-668
Pancreatic cancer is the fourth leading cause of cancer death in the United States. It is highly aggressive with no uniformly effective chemotherapy available for metastatic disease. The sodium-iodide symporter (NIS) is a transmembrane protein respon
Autor:
Neziha Cengic, Christine Spitzweg, I V Scholz, John C. Morris, Richard G. Vile, Kevin J. Harrington, Claire H. Baker, Elizabeth R. Bergert, Burkhard Göke, K Maletz
Publikováno v:
Gene Therapy. 12:272-280
We investigated the feasibility of using radioiodine therapy in colon carcinoma cells (HCT 116) following tumor-specific expression of the human sodium iodide symporter (hNIS) using the carcinoembryonic antigen (CEA) promoter. HCT 116 cells were stab
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:5627-5632
The ability of thyroid cancers to concentrate radioiodine (RAI) is dependent, in part, upon the expression and functional integrity of the sodium iodide symporter (NIS). However, some differentiated thyroid carcinomas (DTCs) and most undifferentiated
Publikováno v:
Current Opinion in Endocrinology & Diabetes. 8:259-265
Autor:
Elizabeth R. Bergert, John C. Morris, Charyl M. Dutton, Armin E. Heufelder, John R. Goellner, Maria R. Castro, Christine Spitzweg
Publikováno v:
Kidney International. 59(3):1013-1023
Expression of the sodium iodide symporter in human kidney. Background The human sodium iodide symporter (hNIS) is a transmembrane protein that mediates the active transport of iodide in the thyroid gland. Following cloning of NIS, NIS expression has
Autor:
Ephraim M. Gabriel, Clive S. Grant, Elizabeth R. Bergert, John C. Morris, Jonathan A. van Heerden, Geoffrey B. Thompson
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:3328-3335
Toxic multinodular goiter (TMNG) represents a frequent cause of endogenous hyperthyroidism, affecting 5-15% of such patients (with higher frequencies reported in iodine-deficient areas of the world). Although mutations of human TSH receptor (hTSHR) h
Autor:
Bryan McIver, John R. Goellner, John C. Morris, Thomas G. Beito, Elizabeth R. Bergert, M. Regina Castro
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:2957-2962
The thyroid sodium-iodide symporter (NIS) is responsible for iodide concentrating ability within thyroid follicular cells. We sought to develop monoclonal antibodies against human NIS (hNIS) for use as reagents in structure-function studies of the pr
Publikováno v:
Nature Biotechnology. 15:439-443
Chimeric analogs derived from pairs of homologous proteins routinely exhibit activities found in one or both parents. We describe chimeras of two glycoprotein hormones, human chorionic gonadotropin (hCG) and human follitropin (hFSH), that exhibit act
Publikováno v:
Autoimmunity. 22:69-79
To examine the interaction of immunoglobulins from patients with newly diagnosed hypothyroidism with the TSH receptor (TSHr), we tested protein-A purified IgG in an ELISA assay with a series of peptides representing the entire extracellular domain (E
Publikováno v:
Journal of Biological Chemistry. 269:30935-30938
The amino acid sequence 256-275 of the human thyrotropin (TSH) receptor extracellular domain has previously been shown to participate in a high affinity TSH binding site by a synthetic peptide approach as well as by site-directed mutagenesis. To furt